An algorithm for the identification of undiagnosed COPD cases using administrative claims data

Journal of Managed Care Pharmacy

Volumn 12, Issue 6, 2006, Pages 458-465

  Mapel, Douglas W ^a   Frost, Floyd J ^b   Hurley, Judith S ^b   Petersen, Hans ^b   Roberts, Melissa ^b   Marton, Jeno P ^c   Shah, Hemal ^d  

^a LOVELACE CLINIC FOUNDATION   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^c US Outcomes Research Group   (United States)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Chronic obstructive pulmonary disease; Diagnosis; Epidemiology; Health care utilization

Indexed keywords

ADMINISTRATIVE PERSONNEL; ADULT; AGED; ALGORITHM; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; FEMALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL RECORD; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; UNITED STATES; CASE CONTROL STUDY; COMPARATIVE STUDY; DISCRIMINANT ANALYSIS; HEALTH SERVICE; INSURANCE; PREDICTION AND FORECASTING; REPRODUCIBILITY; STATISTICAL MODEL; UTILIZATION REVIEW;

ANTIASTHMATIC AGENT; RESPIRATORY TRACT AGENT;

ADULT; AGED; ALGORITHMS; ANTI-ASTHMATIC AGENTS; CASE-CONTROL STUDIES; DISCRIMINANT ANALYSIS; HEALTH SERVICES; HUMANS; INSURANCE CLAIM REVIEW; LOGISTIC MODELS; MANAGED CARE PROGRAMS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; NEW MEXICO; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RESPIRATORY SYSTEM AGENTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SMOKING;

EID: 34548660113     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2006.12.6.458     Document Type: Article

References (19)

1. Lethbridge-Cejku M, Schiller JS, Bernadel L. Summary health statistics for U.S. adults: National Health Interview Survey, 2002. National Center for Health Statistics. Vital Health Stat 10. 2004;222;1-151.
2. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003;123:1684-92.
3. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ. 2002;51:1-16.
4. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-1994 (NHANES III). Hyattsville, MD: U.S. Department of Health and Human Services, Public Health Service, CDC; 1994.
5. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000;160:1683-89.
6. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease. Chest. 2003;124:474-81.
7. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med. 2001;164:372-77.
8. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142:233-39.
9. Petty TL. Scope of the COPD problem in North America. Early studies of prevalence and NHANES III data: basis for early identification and intervention. Chest. 2000;117(suppl):326S-331S.
10. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest. 2000;117:1146-61.
11. Man SFP, McAlister FA, Anthonisen NR, Sin DD. Contemporary management of chronic obstructive pulmonary disease. JAMA. 2003;290:2313-16.
12. Petty TL. Benefits of and barriers to the widespread use of spirometry. Curr Opin Pulm Med. 2005;11:115-20.
13. von Weel C. Underdiagnosis of asthma and COPD: is the general practitioner to blame? Monaldi Arch Chest Dis. 2002;57:65-68.
14. Stratelis G, Jakobsson P, Molstad S, Zetterstrom O. Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract. 2004;54:201-06.
15. Buffels J, Degryse J, Heyrman J, Decramer M. Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO study. Chest. 2004;125:1394-99.
16. Mapel DW, Hurley JS, Frost FJ, Peterson HV, Picchi MA, Coultas DB. Health care utilization in chronic obstructive pulmonary disease: a case-controlled study in a health maintenance organization. Arch Intern Med. 2000;160:2653-58.
17. Mapel DW, Picchi MA, Hurley JS, Frost FJ, Peterson HV, Coultas DB. Utilization in chronic obstructive pulmonary disease: patient characteristics and diagnostic evaluation. Chest. 2000;117(suppl):346S-353S.
18. Mapel DW, McMillan GP, Frost FJ, et al. Predicting the costs of managing patients with chronic obstructive pulmonary disease. Respir Med. 2005;99:1325-33.
19. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE, and the Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142:233-39.